MAPT and Alzheimer disease: The findings suggest that enhancing functional connectivity of the medial temporal lobe could serve as a potential therapeutic target, offering a promising avenue for future clinical interventions aimed at mitigating tau-related neurodegeneration in AD, particularly among those with elevated cortical Aβ.